Drug ID: 1d00000063
Drug Name: Alpha One-proteinase inhibitor
Generic Names: Zemaira
Category: Blood Modifier Agents
Legal Status: Non Opioid Prescription only drug
Indication for Mother: Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Recommended Dose: The recommended dose is 60-mg/kg body weight administered once weekly.
Recommended In: This medication is an alpha-1 protease inhibitor, prescribed for emphysema. It protects tissues from enzymes of inflammatory cells.
Directions For Use: It comes as a solution for injection to be administered by a healthcare provider into the vein.
Storage: Store it in room temperature (25°C).
Dosage Forms: Intravenous Injection
Side Effects: Most Common - Weakness, injection site pain, dizziness, headache, tingling, and itching.
Miscellaneous - Upper respiratory tract infection, inflammation sinus, injection site bleeding, sore throat, fever, runny nose, asthma, chest pain, increased cough, rash, and infection.
In Case of Overdose: If overdose suspected, immediately contact nearby doctor or hospital.
Avoid If: Caution should be exercised in patients with history of heart or circulatory problems, any allergy, who are taking other medications, children, during pregnancy and breastfeeding.
It may cause dizziness, do not drive a car or operate machinery while taking this medication.
Drug Interaction: No data available.